These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 7518280)

  • 1. New targets for pyrimidine antimetabolites in the treatment of solid tumours. 1: Thymidylate synthase.
    van der Wilt CL; Peters GJ
    Pharm World Sci; 1994 Apr; 16(2):84-103. PubMed ID: 7518280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pemetrexed in the treatment of colorectal cancer.
    Hochster H
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):54-6. PubMed ID: 12571812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New concepts for the development and use of antifolates.
    Chu E; Grem JL; Johnston PG; Allegra CJ
    Stem Cells; 1996 Jan; 14(1):41-6. PubMed ID: 8820950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors.
    Rustum YM; Harstrick A; Cao S; Vanhoefer U; Yin MB; Wilke H; Seeber S
    J Clin Oncol; 1997 Jan; 15(1):389-400. PubMed ID: 8996166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future potential of thymidylate synthase inhibitors in cancer therapy.
    Lehman NL
    Expert Opin Investig Drugs; 2002 Dec; 11(12):1775-87. PubMed ID: 12457437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of thymidylate synthase and glycinamide ribonucleotide transformylase.
    Jackson RC
    Adv Exp Med Biol; 1994; 370():179-83. PubMed ID: 7660885
    [No Abstract]   [Full Text] [Related]  

  • 7. Thymidylate synthase: a critical target in cancer therapy?
    Rustum YM
    Front Biosci; 2004 Sep; 9():2467-73. PubMed ID: 15353299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer antifolates: current status and future directions.
    McGuire JJ
    Curr Pharm Des; 2003; 9(31):2593-613. PubMed ID: 14529544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standing the test of time: targeting thymidylate biosynthesis in cancer therapy.
    Wilson PM; Danenberg PV; Johnston PG; Lenz HJ; Ladner RD
    Nat Rev Clin Oncol; 2014 May; 11(5):282-98. PubMed ID: 24732946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidylate synthase: a critical target for cancer chemotherapy.
    Rose MG; Farrell MP; Schmitz JC
    Clin Colorectal Cancer; 2002 Feb; 1(4):220-9. PubMed ID: 12450420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase: a target for combination therapy and determinant of chemotherapeutic response in colorectal cancer.
    Van Triest B; Peters GJ
    Oncology; 1999 Oct; 57(3):179-94. PubMed ID: 10545786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Fluoropirimidines in Gastrointestinal Tumours: from the Bench to the Bed.
    Hernando-Cubero J; Matos-García I; Alonso-Orduña V; Capdevila J
    J Gastrointest Cancer; 2017 Jun; 48(2):135-147. PubMed ID: 28397102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs in therapy of colorectal cancer: preclinical studies.
    Rustum YM; Cao S
    Semin Oncol; 1999 Dec; 26(6):612-20. PubMed ID: 10606254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidylate synthase and drug resistance.
    Peters GJ; van der Wilt CL; van Triest B; Codacci-Pisanelli G; Johnston PG; van Groeningen CJ; Pinedo HM
    Eur J Cancer; 1995; 31A(7-8):1299-305. PubMed ID: 7577040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Morton CL; Adkins DA; Rahman A
    Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifolates: the next millennium.
    Allegra CJ
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):1-2. PubMed ID: 10598548
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymidylate synthase inhibitors.
    Danenberg PV; Malli H; Swenson S
    Semin Oncol; 1999 Dec; 26(6):621-31. PubMed ID: 10606255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raltitrexed. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer.
    Gunasekara NS; Faulds D
    Drugs; 1998 Mar; 55(3):423-35. PubMed ID: 9530547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase inhibition, a dead end?
    Herrmann R
    Eur J Cancer; 1995 Nov; 31A(12):1919-20. PubMed ID: 8562141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.